LEVIS, Mario
Dettaglio
LEVIS, Mario
ONCOLOGIA
Pubblicazioni
Risultati 1 - 20 di 38 (tempo di esecuzione: 0.002 secondi).
Titolo | Data di pubblicazione | Autore(i) | |
---|---|---|---|
1 | Adoption of Expansion Margins to Reduce the Dose Received by the Coronary Arteries and the Risk of Cardiovascular Events in Lymphoma Patients | 2021 | De Luca V.; Gallio E.; Bartoncini S.; Giglioli F.R.; Sardo A.; Cavallin C.; Iorio G.C.; Orlandi E.; Parise R.; Palladino C.; Buonavita A.; Fiandra C.; Levis M.; Ricardi U. |
2 | Applying radiation protection and safety in radiotherapy | 2019 | Magrini S.M.; Pasinetti N.; Belgioia L.; Triggiani L.; Levis M.; Ricardi U.; Corvo R. |
3 | Biochemical and clinical outcomes after high-dose salvage radiotherapy as monotherapy for prostate cancer. | 2014 | Botticella A;Guarneri A;Levra NG;Munoz F;Filippi AR;Rondi N;Badellino S;Arcadipane F;Levis M;Ragona R;Ricardi U |
4 | Contrast-induced kidney injury: How does it affect long-term cardiac mortality? | 2017 | Andreis A.; Budano C.; Levis M.; Garrone P.; Usmiani T.; D'Ascenzo F.; De Filippo O.; D'Amico M.; Bergamasco L.; Biancone L.; Marra S.; Colombo A.; Gaita F. |
5 | Definitive radiotherapy for localized follicular lymphoma staged by 18F-FDG PET-CT: a collaborative study by ILROG | 2019 | Brady, Jessica L; Binkley, Michael S; Hajj, Carla; Chelius, Monica; Chau, Karen; Balogh, Alex; Levis, Mario; Filippi, Andrea Riccardo; Jones, Michael; Mac Manus, Michael; Wirth, Andrew; Oguchi, Masahiko; Krog Vistisen, Anders; Andraos, Therese Youssef; Ng, Andrea K; Aleman, Berthe M P; Choi, Seo Hee; Kirova, Youlia; Hardy, Sara; Reinartz, Gabriele; Eich, Hans T; Bratman, Scott V; Constine, Louis S; Suh, Chang-Ok; Dabaja, Bouthaina; El-Galaly, Tarec C; Hodgson, David C; Ricardi, Umberto; Yahalom, Joachim; Hoppe, Richard T; Mikhaeel, N George |
6 | Efficacy of low-dose radiotherapy (2 Gy × 2) in the treatment of marginal zone and mucosa-associated lymphoid tissue lymphomas | 2021 | Cerrato M.; Orlandi E.; Vella A.; Bartoncini S.; Iorio G.C.; Bongiovanni D.; Capriotti F.; Boccomini C.; Vassallo F.; Cavallin C.; De Luca V.; Giglioli F.R.; Ricardi U.; Levis M. |
7 | Extranodal Marginal Zone Lymphoma | 2017 | Ricardi, Umberto; Filippi, Andrea Riccardo; Pica, Cristina; Levis, Mario |
8 | Fondazione Italiana Linfomi (FIL) expert consensus on the use of intensity-modulated and image-guided radiotherapy for Hodgkin's lymphoma involving the mediastinum | 2020 | Filippi A.R.; Meregalli S.; Di Russo A.; Levis M.; Ciammella P.; Buglione M.; Guerini A.E.; De Marco G.; De Sanctis V.; Vagge S.; Ricardi U.; Simontacchi G. |
9 | Immune checkpoint inhibitors in combination with radiotherapy as salvage treatment for relapsed/refractory classical hodgkin lymphoma: A retrospective analysis in 12 patients | 2021 | Lucchini E.; Rusconi C.; Levis M.; Ricci F.; Santoro A.; Ricardi U.; Volpetti S.; Matrone F.; Di Russo A.; Caizzi M.; Schiattarella A.; Zaja F. |
10 | Impact of contrast-induced acute kidney injury definition on clinical outcomes | 2011 | Budano C.; Levis M.; D'Amico M.; Usmiani T.; Fava A.; Sbarra P.; Burdese M.; Segoloni G.P.; Colombo A.; Marra S. |
11 | Impact of the observers' experience on daily prostate localization accuracy in ultrasound-based IGRT with the Clarity platform | 2014 | Fiandra C;Guarneri A;Munoz F;Moretto F;Filippi AR;Levis M;Ragona R;Ricardi U |
12 | Inclusion of heart substructures in the optimization process of volumetric modulated arc therapy techniques may reduce the risk of heart disease in Hodgkin's lymphoma patients | 2019 | Levis M.; Filippi A.R.; Fiandra C.; De Luca V.; Bartoncini S.; Vella D.; Ragona R.; Ricardi U. |
13 | An integrated approach to cardioprotection in lymphomas | 2022 | Maraldo, Maja V; Levis, Mario; Andreis, Alessandro; Armenian, Saro; Bates, James; Brady, Jessica; Ghigo, Alessandra; Lyon, Alexander R; Manisty, Charlotte; Ricardi, Umberto; Aznar, Marianne C; Riccardo Filippi, Andrea |
14 | Left main minimal plaque burden complicated by an acute massive thrombosis: Diagnostic and therapeutic strategies | 2011 | Scacciatella P.; Ebrille E.; Infantino V.; Amato G.; Levis M.; Marra S. |
15 | Modern Radiation Therapy for the Management of Brain Metastases From Non-Small Cell Lung Cancer: Current Approaches and Future Directions | 2021 | Mantovani C.; Gastino A.; Cerrato M.; Badellino S.; Ricardi U.; Levis M. |
16 | Optimal Therapy for Early-Stage Hodgkin’s Lymphoma: Risk Adapting, Response Adapting, and Role of Radiotherapy | 2017 | Filippi, Andrea Riccardo; Levis, Mario; Parikh, Rahul; Hoppe, Bradford |
17 | Outcomes of Single Fraction Stereotactic Ablative Radiotherapy for Lung Metastases | 2014 | Filippi AR; Badellino S; Guarneri A; Levis M; Botticella A; Mantovani C; Ragona R; Racca P; Buffoni L; Novello S; Ricardi U |
18 | Plan optimization for mediastinal radiotherapy: Estimation of coronary arteries motion with ECG-gated cardiac imaging and creation of compensatory expansion margins | 2018 | Levis, Mario; De Luca, Viola; Fiandra, Christian; Veglia, Simona; Fava, Antonella; Gatti, Marco; Giorgi, Mauro; Bartoncini, Sara; Cadoni, Federica; Garabello, Domenica; Ragona, Riccardo; Filippi, Andrea Riccardo*; Ricardi, Umberto |
19 | Potential Benefit of Involved-Field Radiotherapy for Patients With Relapsed-Refractory Hodgkin's Lymphoma With Incomplete Response Before Autologous Stem Cell Transplantation | 2017 | Levis, Mario; Piva, Cristina; Filippi, Andrea Riccardo; Botto, Barbara; Gavarotti, Paolo; Pregno, Patrizia; Nicolosi, Maura; Freilone, Roberto; Parvis, Guido; Gottardi, Daniela; Vitolo, Umberto; Ricardi, Umberto |
20 | Prognostic role of pre-radiation therapy 18F-fluorodeoxyglucose positron emission tomography for primary mediastinal B-cell lymphomas treated with R-CHOP or R-CHOP-like chemotherapy plus radiation | 2016 | Filippi, Andrea Riccardo; Piva, Cristina; Levis, Mario; Chiappella, Annalisa; Caracciolo, Daniele; Bellò, Marilena; Bisi, Gianni; Vitolo, Umberto; Ricardi, Umberto |